Shire-NPS Pharmaceuticals, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in 1986, the company has established itself as a leader in developing innovative therapies for rare diseases, particularly in the fields of gastrointestinal and endocrine disorders. With a strong focus on patient-centric solutions, Shire-NPS offers a range of unique products, including treatments for conditions such as short bowel syndrome and hypoparathyroidism. The company’s commitment to research and development has led to significant milestones, including the successful launch of several groundbreaking therapies. Recognised for its expertise in rare disease management, Shire-NPS Pharmaceuticals continues to strengthen its market position, making a meaningful impact on the lives of patients worldwide.
We don't have data for Shire-NPS Pharmaceuticals, Inc., but we can show you information about their parent organization instead.
View parent company